European Journal of Pharmacology 1994 - 1995: Vol 271-293 Index

213 Pages·48.7 MB·English

an international journal
ELSEVIER
Master Author and Keyword Indexes, Volumes 271-293, 1995
(EJP Molecular Pharmacology Section, Volumes 288-291, and EJP Environmental Toxicology
and ~~? Section, Volumes 292-293, incorporated)

EUROPEAN JOURNAL OF PHARMACOLOGY
INDEXES 1995

european journal of
pharmacology
Author and Keyword Indexes, 1995
Volumes 271-293
(EJP Molecular Pharmacology Section, Volumes 288-291, and EJP Environmental
Toxicology and Pharmacology Section, Volumes 292-293, incorporated)
AMSTERDAM — LAUSANNE — NEW YORK — OXFORD - SHANNON - TOKYO
© 1996 Elsevier Science B.V. All rights reserved
No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical,
photocopying, recording or otherwise, without the prior written permission of the publisher, Elsevier Science B.V., Copyright and Permissions Department,
P.O. Box 521, 1000 AM Amsterdam, The Netherlands.
No responsibility is assumed by the publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise,
or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of the rapid advances in the medical
sciences, independent verification of diagnoses and drug dosages should be made.
Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or
endorsement of the quality or value of such product or of the claims made of it by its manufacturer.
Special regulations for authors. Upon acceptance of an article by the journal, the author(s) will be asked to transfer copyright of the article to the publisher.
This transfer will ensure the widest possible dissemination of information.
Special regulations for readers in the U.S.A. This journal has been registered with the Copyright Clearance Center, Inc. Consent is given for copying of
articles for personal or internal use, or for the personal use of specific clients. This consent is given on the condition that the copier pays through the Center
the per-copy fee stated in the code on the first page of each article for copying beyond that permitted by Sections 107 or 108 of the U.S. Copyright Law. The
appropriate fee should be forwarded with a copy of the first page of the article to the Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA
01923, U.S.A., Tel.: (S08) 750-8400; FAX: [phone]. If no code appears in an article, the author has not given broad consent to copy and permission
to copy must be obtained directly from the author. The fee indicated on the first page of an article in this issue will apply retroactively to all articles
published in the journal, regardless of the year of publication. This consent does not extend to other kinds of copying, such as for general distribution, resale,
advertising and promotion purposes, or for creating new collective works. Special written permission must be obtained from the publisher for such copying.
This journal is in the ADONIS Service, whereby copies of individual articles can be printed out from CD-ROM on request. An explanatory leaflet can be
obtained by writing to ADONIS B.V., P.O. Box 839, 1000 AV Amsterdam, The Netherlands.
Publication information
European Journal of Pharmacology (ISSN 0014-2999). As of 1996 the journal is no longer divided into sections. For 1996, volumes 294-316 are scheduled
for publication. Vol. 294 appeared in 1995 but remains the first volume of the 1996 subscription year.
Subscription prices are available upon request from the publisher. Subscriptions are accepted on a prepaid basis only and are entered on a calendar year
basis. Issues are sent by surface mail except to the following countries where air delivery via SAL mail is ensured: Argentina, Australia, Brazil, Canada,
Hong Kong, India, Israel, Japan, Malaysia, Mexico, New Zealand, Pakistan, PR China, Singapore, South Africa, South Korea, Taiwan, Thailand, USA. For
all other countries airmail rates are available upon request.
Claims for missing issues must be made within six months of our publication (mailing) date.
Please address all your requests regarding orders and subscription queries to: Elsevier Science B.V., Journal Department, P.O. Box 211, 1000 AE
Amsterdam, The Netherlands. Tel.: [phone], Fax: [phone].
All questions arising after acceptance of a manuscript by the editor, especially those relating to proofs, publication and reprints, should be directed to the
publisher, Elsevier Science B.V., P.O. Box 1527, 1000 BM Amsterdam, The Netherlands (Fax: [phone]). Address for courier service: Molenwerf 1,
1014 AG Amsterdam, The Netherlands.
In the U.S.A. and Canada: for further information and personal subscriptions, contact Elsevier Science Inc., Journal Information Center, 655 Avenue of the
Americas, New York, NY 10010, U.S.A. (Tel.: [phone]; Fax: [phone]; Telex: 420.643 AEP UI).
Advertising information: Advertising orders and enquiries may be sent to:
International: Elsevier Science, Advertising Department, The Boulevard, Langford Lane, Kidlington, Oxford, OXS 1GB, UK; Tel. (+44) (0) 1865 843565;
Fax (+44) (0) 1865 843952.
USA & Canada: Weston Media Associates, Dan Lipner, P.O. Box 1110, Greens Farms, CT 06436-1110, USA; Tel. [phone]; Fax: [phone].
Japan: Elsevier Science Japan, Ms Noriko Kodama, 20-12 Yushima, 3 chome, Bunkyo-Ku, Tokyo 113, Japan; Tel. [phone]; Fax [phone]
4344.
© The paper used in this publication meets the requirements of ANSI/NISO 239.48-1992 (Permanence of Paper).
US mailing notice - European Journal of Pharmacology (ISSN 0014-2999) is published weekly by Elsevier Science B.V. (Molenwerf 1, Postbus 211, 1000
AE Amsterdam, The Netherlands). Annual subscription price in the USA is US$ 5680.00 (valid in North, Central and South America only) including air
speed delivery. Second class postage rate is paid at Jamaica, NY 11431.
USA POSTMASTERS: Send address changes to European Journal of Pharmacology, Publications Expediting, Inc., 200 Meacham Avenue, Elmont,
NY 11003.
Airfreight and mailing in the USA by Publications Expediting.
Printed in The Netherlands
European Journal of Pharmacology
Master author index to volumes 271-293 ( 1995)
Aarts, J.M.MJ.G., Denison, M.S., Cox, M.A., Schalk, M.A.C., Garrison, Agabio, R., see Colombo, G. (273) 235
P.M., Tullis, K., De Haan, L.HJ. and Brouwer, A. Agabio, R., see Colombo, G. (285) 103
Species-specific antagonism of Ah receptor action by 2,2',5,5’-tetra- Agapito-Serrano, M.T., see Lépez-Burillo, S. (289) 259
chloro- and 2,2’ 3,3’ ,4,4’-hexachlorobiphenyl (293) 463 Agnati, L.F., see Yang, S.-N. (271) 201
Abad, F., Maroto, R., Lépez, M.G., Sanchez-Garecia, P. and Garcia, A.G. Agrawal, K.C., see Kaye, A.D. (276) 21
Pharmacological protection against the cytotoxicity induced by 6-hy- Aguirre, N., Galbete, J.L., Lasheras, B. and Del Rio, J.
droxydopamine and H,O, in chromaffin cells (293) 55 Methylenediox ymethamphetamine induces opposite changes in cen-
Abadji, V., see Pertwee, R.G. (272) 73 tral pre- and postsynaptic 5-HT,, receptors in rats (281) 101
Abbott, F.V., see Hong, Y. (277) 21 Ahier, R.G., see Hume, S.P. (271) 515
Abdel Ghani, E.M., see Storch, A. (290) 207 Ahlborg, U.G., see Brouwer, A. (293) |
Abdi, S., Traber, L.D., Herndon, D.N., Rogers, C.S. and Traber, D.L. Ahlborg, U.G., see Hemming, H. (292) 241
Effects of ibuprofen on airway vascular response to cotton smoke Ahluwalia, A., Newbold, P., Brain, S.D. and Flower, RJ.
injury (293) 475 Topical glucocorticoids inhibit neurogenic inflammation: involvement
Abdul-Ghaffar, T., see Canfield, P. (273) | of lipocortin | (283) 193
Abe, Y., see He, H. (273) 209 Ahmed, G., see Parmar, D.V. (293) 225
Abiko, Y., see Hashizume, H. (271) | Ahn, H.-S., Foster, M., Arik, L., Boykow, G. and Foster, C.
Abiko, Y., see Kamigaki, M. (287) 121 Cyclic nucleotide phosphodiesterase isozymes in rat mesangial cells
Abiru, T., Endo, K. and Machida, H. (289) 49
Differential vasodilatory action of 2-octynyladenosine (YT-146), an Ahrén, B., Karlsson, S., Scheurink, AJ.W. and Steffens, A.B.
adenosine A, receptor agonist, in the isolated rat femoral artery and Involvement of nitric oxide in neuroglycopenia-induced insulin and
vein (281) 9 glucagon secretion in the mouse (280) 27
Ableitner, A. Aikawa, N., see Adachi, T. (286) 201
Brain sites involved in 5-opioid receptor-mediated actions (271) 213 Aiyar, N., Baker, E., Vickery-Clark, L., Ohlstein, E.H., Gellai, M.,
Abram, T., see Gorenne, I. (275) 207 Fredrickson, T.A., Brooks, D.P., Weinstock, J., Weidley, E.F. and
Abram, T.S., see Norman, P. (271) 73 Edwards, R.M.
Aburto, T., Jinsi, A., Zhu, QB. and Deth, R.C. Pharmacology of a potent long-acting imidazole-S-acrylic acid an-
Involvement of protein kinase C activation in a,-adrenoceptor- giotensin AT, receptor antagonist (283) 63
mediated contractions of rabbit saphenous vein (277) 35 Akahane, A., see Terai, T. (279) 217
Aceto, M.D., Scates, S.M., Lowe, J.A. and Martin, B.R. Akaike, N., see Uneyama, C. (291) 381
Cannabinoid precipitated withdrawal by the selective cannabinoid Akarasereenont, P., Mitchell, J.A., Bakhle, Y.S., Thiemermann, C. and
receptor antagonist, SR 141716A (282) RI Vane, J.R.
Acri, J.B., Carter, S.R., Alling, K., Geter-Douglass, B., Dijkstra, D., Comparison of the induction of cyclooxygenase and nitric oxide
Wikstrém, H., Katz, J.L. and Witkin, J.M. synthase by endotoxin in endothelial cells and macrophages (273) 121
Assessment of cocaine-like discriminative stimulus effects of Akehira, K., Nakane, Y., Hioki, K. and Taniyama, K.
dopamine D, receptor ligands (281) R7 Site of action of galanin in the cholinergic transmission of guinea pig
Acri, J.B., Wong, G. and Witkin, J.M. small intestine (284) 149
Stereospecific transduction of behavioral effects via diazepam-insensi- Akerman, K.E.O., see Jansson, C.C. (290) 75
tive GABA, receptors (278) 213 Akerman, K.E.O., see Jarv, J. (291) 43
Adachi, T., Hori, S., Miyazaki, K., Takahashi, E., Nakagawa, M., Uda- Aki, Y., see He, H. (273) 209
gawa, A., Hayashi, N., Aikawa, N. and Ogawa, S. Akiba, S., Nagatomo, R., Ishimoto, T. and Sato, T.
Rapid increase in plasma nitrite concentration following intravenous Effect of berbamine on cytosolic phospholipase A, activation in
administration of nipradilol (286) 201 rabbit platelets (291) 343
Adams, J.U., see Chen, X.-H. (275) 105 Akiyama, K., see Hashizume, H. (271) |
Adcock, I.M., see Peters, MJ. (289) 275 Akiyama, K., see Sutoo, D. (278) 33
Adeli, R., see Zarrindast, M.-R. (276) 3 Akkermans, L.M.A., see Briejer, M.R. (279) 123
Adelman, J.P., see Lee, K. (285) 309 Akuzawa, S., Miyata, K. and Fukutomi, H.
Adelroth, E., see Stevens, W.H.M. (293) 251 Characterization of [>H ]YM060, a potent and selective 5-HT, recep-
Adler, M.W., see Chen, X.-H. (275) 105 tor radioligand, in the cerebral cortex of rats (281) 37
Adomeit, A., see Liebmann, C. (289) 403 Alaoui, F., Pratt, J., Trocherie, $., Court, L. and Stutzmann, J.-M.
Advenier, C., see Bétoin, F. (279) 241 Acute effects of irradiation on the rat brain: protection by glutamate
Advenier, C., see Félétou, M. (274) 57 blockade (276) 55
Advenier, C., see Molimard, M. (278) 49 Albin, R.L., see Feeley Kearney, J.A. (287) 115
Advenier, Ch., see Molimard, M. (278) 253 Albuquerque, E.X., see Storch, A. (290) 207
ro, C.E., see Rashol, H. (286) 9 Alcaraz, M_J., see Gil, B. (285) 281
Master author index to volumes 271-293 (1995)
Alemany, R., Olmos, G., Escribé, P.V., Menargues, A., Obach, R. and Aoyagi, T., see Majima, M. (284) |
Garcia-Sevilla, J.A. Aoyagi, T., see Sata, M. (290) 55
LSL 60101, a selective ligand for imidazoline |, receptors, on glial Apaydin, S., see Van der Graaf, P.H. (287) 309
fibrillary acidic protein concentration (280) 205 Aragonés, M.D., see Catalan, R.E. (290) 183
Alexander, P.B. and Cheung, D.W. Arai, T., see Hagihara, K. (271) 159
Ca** mobilization by caffeine in single smooth muscle cells of the rat Arakawa, H., see Kawikova, I. (280) 293
tail artery (288) 79 Araki, H., see Uchiyama-Tsuyuki, Y. (293) 245
Allard, M., see Garay, R.P. (274) 175 Araki, T., Kato, H., Fujiwara, T., Kogure, K. and Itoyama, Y.
Allard, M.F., see Schénekess, B.O. (286) 155 Post-ischemic changes of (*H]glycine binding in the gerbil brain after
Allen, G.T., see Tesfamariam, B. (281) 17 cerebral ischemia (278) 91
Allen, J., see Le Rouzic, M. (278) 261 Araki, T., see Kato, H. (272) 107
Allen, M.J. and Coleman, R.A. Arbaoui, J., see Protais, P. (271) 167
B,-Adrenoceptors mediate a reduction in endothelial permeability in Arbilla, S., see Le Rouzic, M. (278) 261
vitro (274) 7 Arce, A., see Esquifino, A.I. (285) 143
Allescher, H.-D., see Franck, H. (271) 379 Arik, L., see Ahn, H.-S. (289) 49
Allescher, H.-D., see Kurjak, M. (281) 295 Arilla, E., see Puebla, L. (289) 361
Allgeier, H., see Kndpfel, T. (288) 389 Arima, T., see Kitamura, Y. (289) 299
Alling, K., see Acri, J.B. (281) R7 Arishima, K., see Naito, H. (272) 261
Allison, K., Ivanova, S. and Greenshaw, A.J. Arletti, R., see Poggioli, R. (271) 253
Behavioural response to SKF 38393 and quinpirole following chronic Arletti, R., see Poggioli, R. (287) 207
antidepressant treatment (277) 139 Armour, C.L., see Anticevich, S.Z. (284) 221
Aloyo, V.J. and Pazdalski, P.S. Amer, A., see Sjuve, R. (276) 137
Evidence that B-endorphin is an agonist at bovine pineal 5-opioid Americ, S.P., see Gopalakrishnan, M. (290) 237
receptors (288) 295 Amt, J., Sanchez, C., Lenz, S.M., Madsen, U. and Krogsgaard-Larsen, P.
Alsasua, A., see Parra, L. (277) 99 Differentiation of in vivo effects of AMPA and NMDA receptor
Altavilla, D., Squadrito, F., Canale, P., loculano, M., Campo, G.M., ligands using drug discrimination methods and convulsant /anticon-
Squadrito, G., Ammendolia, L. and Caputi, A.P. vulsant activity (285) 289
E-selectin involvement in the pathogenesis of splanchnic artery occlu- Amt, J.
sion shock (272) 223 Differential effects of classical and newer antipsychotics on the
Altavilla, D., Squadrito, F., Canale, P., loculano, M., Squadrito, G., hypermotility induced by two dose levels of D-amphetamine (283) 55
Campo, G.M., Serrand, M., Sardella, A., Urna, G., Spignoli, G. and Arreola, J., Dirksen, R.T., Perez~Comejo, P., Piech, K.M. and Sheu, S.-S.
Caputi, A.P. Autonomic modulation of action potential and tension in guinea pig
G 619, a dual thromboxane synthase inhibitor and thromboxane A , papillary muscles (271) 309
receptor antagonist, inhibits tumor necrosis factor-a biosynthesis Arrigoni-Martelli, E., see Maresca, P. (287) 303
(286) 31 Asagoe, K., Murakami, M. and Kita, T.
Altier, H., see Ponzoni, A. (278) 111 Histamine chloramines have a persistent stimulating effect on his-
Amakata, Y., see Sai, Y. (282) 235 tamine H, receptors and gastric acid secretion (275) 179
Amann, R., Schuligoi, R., Lanz, 1. and Donnerer, J. Asano, S., see Matsuda, T. (280) 235
Histamine-induced edema in the rat paw — effect of capsaicin dener- Ashford, M.L.J., see Lee, K. (280) 215
vation and a CGRP receptor antagonist (279) 227 Ashkenazi, R., see Fonia, O. (293) 335
Ammendolia, L., see Altavilla, D. (272) 223 Ashworth-Preece, M.A., see Routledge, C. (276) 281
Amobi, N. and Smith, LC.H. Ashworth, S., see Hume, S.P. (271) 515
The human vas deferens: correlation of response pattern to nor- Asker, D.S., see Waterfield, CJ. (293) 141
adrenaline and histological structure (273) 25 Astier, H., see Roussel, J.-P. (289) 205
Andersen, J.V., see Videbak, C. (281) 117 Atke, A., Vilhardt, H., Hauzerova, L., Barth, T. and Andersen, L.F.
Andersen, L.F., see Atke, A. (281) 63 Effects of the non-peptide inhibitor OPC-21268 on oxytocin and
Anderson, D.J., see Decker, M.W. (280) 79 vasopressin stimulation of rat and human myometrium (281) 63
Andersson, I., see Westlind-Danielsson, A. (288) 89 Atkinson, A.M., see Teale, D.M. (271) 87
Ando, H., see Hotta, Y. (282) 121 Audet, R., Petitclerc, E., Drapeau, G., Rioux, F. and Marceau, F.
Ando, T., see Terai, T. (279) 217 Further analysis of the upregulation of bradykinin B, receptors in
Andrews, P.L.R., see Woods, A.J. (278) 275 isolated rabbit aorta by using metabolic inhibitors (271) 551
Andrzejewski, W., see Tuomisto, J. (292) 277 Audinot, V., see Millan, M.J. (280) 225
Angel, I., see Le Rouzic, M. (278) 261 Auguet, M., Delaflotte, S. and Chabrier, P.-E.
Ansay, M., see Delaunois, A. (277) 243 Different a,-adrenoceptor subtypes mediate contraction in rabbit
Anticevich, S.Z., Hughes, J.M., Black, J.L. and Armour, C.L. aorta and urethra (287) 153
Induction of human airway hyperresponsiveness by tumour necrosis Aulakh, C.S., Mazzola-Pomietto, P. and Murphy, D.L.
factor-a (284) 221 Long-term antidepressant treatments alter 5-HT,, and 5-HT,- recep-
Antunes, E., see Grassi-Kassisse, D.M. (282) 57 tor-mediated hyperthermia in Fawn-Hooded rats (282) 65
Antunes, E., see Medeiros, M.V. (285) 109 Aydin, S., see Buyukuysal, R.L. (281) 179
Antunes, E., see Moreno, Jr., H. (287) 93 Az-ma, T., Fujii, K. and Yuge, O.
Anwyl, R., see Wu, J. (284) R1 Inhibitory effect of sevoflurane on nitric oxide release from cultured
Anzai, M., Suzuki, Y., Takayasu, M., Kajita, Y., Mori, Y., Seki, Y., endothelial cells (289) 33
Saito, K. and Shibuya, M.
Vasorelaxant effect of PACAP-27 on canine cerebral arteries and rat Baba, A., see Matsuda, T. (280) 235
intracerebral arterioles (285) 173 Badesha, J.S., Maliji, G. and Flaks, B.
Aono, T., see Hamada, Y. (288) 45 Immunotoxic effects of prolonged dietary exposure of male rats to
Aoto, N., see Sakitama, K. (273) 47 2,3,7,8-tetrachlorodibenzo-p-dioxin (293) 429
Master author index to volumes 271-293 (1995)
Bagdy, G. and Makara, G.B. Bargas, J., see Pineda, J.C. (281) 271
Paraventricular nucleus controls 5-HT,. receptor-mediated corticos- Barnard, E.A., see Simon, J. (291) 281
terone and prolactin but not oxytocin and penile erection responses Barnes, PJ., see Belvisi, M. (283) 255
(275) 301 Barnes, P.J., see Haddad, E.-B. (290) 201
Bager, Y., see Hemming, H. (292) 241 Barnes, PJ., see Haddad, E.-B. (293) 287
Bagrov, A.Y., Roukoyatkina, N.I., Pinaev, A.G., Dmitrieva, R.I. and Barnes, PJ., see Hayes, J.P. (292) 127
Fedorova, O.V. Barnes, PJ., see Peters, MJ. (289) 275
Effects of two endogenous Na*,K*-ATPase inhibitors, marinobufa- Barnett, C.R., see Irizar, A. (293) 385
genin and ouabain, on isolated rat aorta (274) 151 Baron, B.M., see Chapman, A.G. (274) 83
Bai, X., see Weiser, S.D. (275) | Baron, B.M., see Kehne, J.H. (284) 109
Baird, A.J., see Grover, GJ. (277) 271 Barr, G., see Franco-Cereceda, A. (279) 105
Baird, A.W., see Keely, S.J. (279) 203 Barrachina, M.D., Calatayud, S., Canet, A., Bello, R., Diaz de Rojas, F.,
Baird, A.W., see O'Malley, K.E. (275) 83 Guth, P.H. and Esplugues, J.V.
Bajaj, B.P.S., see Balmforth, AJ. (291) 135 Transdermal nitroglycerin prevents nonsteroidal anti-inflammatory
Baker, E., see Aiyar, N. (283) 63 drug gastropathy (281) R3
Bakhle, Y.S., see Akarasereenont, P. (273) 121 Barrachina, M.D., Calatayud, S., Moreno, L., Martinez-Cuesta, M.A.,
Balaklievskaia, N., see Colombo, G. (285) 103 Whittle, B.J.R. and Esplugues, J.V.
Balasubramaniam, E., see Paul, V. (293) 355 Nitric oxide and sensory afferent neurones modulate the protective
Balasubramaniam, G., Lee, H.S. and Mah, S.C. effects of low-dose endotoxin on rat gastric mucosal damage (280)
5-Carboxamidotryptamine attenuates the development of deoxycorti- 339
costerone acetate-salt hypertension in rats (276) 183 Barrenscheen, M., see Schmalix, W.A. (293) 123
Balboni, G., see Damgé, C. (274) 133 Barrett, T.D., Hayes, E.S. and Walker, MJ.A.
Balestra, B., see Messori, E. (286) 205 Lack of selectivity for ventricular and ischaemic tissue limits the
Ball, D.I., see Beresford, 1.J.M. (272) 241 antiarrhythmic actions of lidocaine, quinidine and flecainide against
Ball, S.G., see Balmforth, AJ. (291) 135 ischaemia-induced arrhythmias (285) 229
Ball, S.G., see Wintersgill, H.P. (288) 365 Barrigén, S., see Salinas, P. (293) 65
Ballati, L., see Perretti, F. (273) 129 Barrios, V.E., see Krause, D.N. (276) 207
Ballejo, G., see Martins, S.L.R. (284) 265 Barth, T., see Atke, A. (281) 63
Balmforth, A.J., Lee, AJ., Bajaj, B.P.S., Dickinson, C.J., Warburton, P. Barthd, L., see Patacchini, R. (278) 17
and Ball, S.G. Bartolome, J.V., Chang, K.-J. and Bartolome, M.B.
Functional domains of the C-terminus of the rat angiotensin AT,, The inhibition of omithine decarboxylase activity in developing rat
receptor (291) 135 tissues by central nervous system B-endorphin is mediated by u-opioid
Balmforth, A.J., see Wintersgill, H.P. (288) 365 receptboutr nsot, b y 5- or €-opioid receptors (284) 43
Balster, R., see Wiley, J. (276) 49 Bartolome, M.B., see Bartolome, J.V. (284) 43
Balster, R.L., see Mansbach, R.S. (274) 167 Basak, A.K., see Koley, J. (293) 483
Balster, R.L., see Woodward, J.J. (277) 7 Bascands, J.-L., see Bompart, G. (278) 225
Baltatu, O., see Brailoiu, E. (281) 209 Baskaya, M.K., see Seki, Y. (275) 259
Baltatu, O., see Costuleanu, M. (281) 89 Basler, I., Kuhn, M., Miller, W. and Forssmann, W.-G.
Baltatu, O., see Filipeanu, C.M. (281) 29 Pituitary adenylate cyclase-activating polypeptide stimulates cardiodi-
Bandopadhyay, R. and De Belleroche, J. latin /atrial natriuretic peptide (CDD /ANP-(9912-6 ) secretion from
Depletion of cortical cholecystokinin levels after excitotoxin injection cultured neonatal rat myocardiocytes (291) 335
into the nucleus basalis: sensitivity to MK-801 (275) 53 Bassi, L., see Fornai, F. (283) 99
Banks, K.E. and Gratton, A. Bast, A., see Smit, M.J. (288) 17
Possible involvement of medial prefrontal cortex in amphetamine-in- Bast, A., see Westerveld, G.-J. (291) 27
duced sensitization of mesolimbic dopamine function (282) 157 Bataille, D., see Gros, L. (288) 319
Bansinath, M., see Shukla, V.K. (292) 293 Baubichon, D., see Bodjarian, N. (289) 291
Baran, H., Gramer, M. and Lischer, W. Bauer, C., see Hocher, B. (293) 361
Alterations in plasma and brain amino acids after administration of Baulieu, E.E., see Hauser, C.A.E. (289) 249
the glycine /NMDA receptor partial agonist, D-cycloserine, to mice Baumann, M.H., Becketts, K.M. and Rothman, R.B.
and rats (273) 197 Evidence for alterations in presynaptic serotonergic function during
Baran, H., Gramer, M., Hénack, D. and Léscher, W. withdrawal from chronic cocaine in rats (282) 87
Systemic administration of kainate induces marked increases of en- Baumann, P., see Knopfel, T. (288) 389
dogenous kynurenic acid in various brain regions and plasma of rats Baumner, D. and Nawrath, H.
(286) 167 Effects of inhibitors of cGMP-dependent protein kinase in atrial heart
Barbeito, L., see Estevez, A.G. (280) 47 and aortic smooth muscle from rats (273) 295
Barbier, AJ. and Lefebvre, R.A. Bax, W.A., Van der Graaf, P.H., Stam, W.B., Bos, E., Nisato, D. and
Relaxant influence of phosphodiesterase inhibitors in the cat gastric Saxena, P.R.
fundus (276) 41 [Arg® ]Vasopressin-induced responses of the human isolated coronary
Barbier, P., Renzetti, A.R., Turbanti, L., Di Bugno, C., Fornai, F., artery: effects of non-peptide receptor antagonists (285) 199
Vaglini, F., Maggio, R. and Corsini, G.U. Bayewitch, M., see Barg, J. (287) 145
Stereoselective inhibition of muscarinic receptor subtypes by the eight Bazan, E., Campbell, A.K. and Rapoport, R.M.
stereoisomers related to rociverine (290) 125 Time course of phorbol ester-induced contraction and protein kinase
Barg, J., Fride, E., Hanus, L., Levy, R., Matus-Leibovitch, N., Heldman, C activation in rat aorta (290) 253
E., Bayewitch, M., Mechoulam, R. and Vogel, Z. Beani, L., see Tanganelli, S. (273) 63
Cannabinomimetic behavioral effects of and adenylate cyclase inhibi- Beattie, D.T. and Connor, H.E.
tion by two new endogenous anandamides (287) 145 The pre- and postjunctional activity of CP-122,288, a conformation-
Barg, J., see Novakova, M. (286) 19 ally restricted analogue of sumatriptan (276) 271
4 Master author index to volumes 271-293 (1995)
Beattie, D.T., see Escott, KJ. (284) 69 Berrino, L., see Leyva, J. (285) 123
Beattie, D.T., see Walsh, D.M. (287) 79 Bertha, C.M., see Bowen, W.D. (278) 257
Beauchemin, V., see Dennis, T. (272) 279 Bertha, C.M., see Bowen, W.D. (279) RI
Becherucci, C., see Palmi, M. (281) 97 Bertolini, A., see Poggioli, R. (271) 253
Beck-Sickinger, A.G., see Rudolf, K. (271) R11! Bertolini, A., see Poggioli, R. (287) 207
Becketts, K.M., see Baumann, M.H. (282) 87 Bertrand, D., see Gopalakrishnan, M. (290) 237
Bédard, P.J., see St-Pierre, J.-A. (272) 123 Bertrand, G., see Berdeu, D. (275) 91
Beenhakker, M., see Von Lubitz, D.K.J.E. (283) 185 Bervoets, K., see Maurel-Remy, S. (280) R9
Behr, J.-P., see Foucaud, B. (289) 471 Berzetei-Gurske, 1.P., White, A., Polgar, W., DeCosta, B.R., Pasternak,
Belai, A., see Ralevic, V. (286) 193 G.W. and Toll, L.
Beleslin, D.B., see Jovanovié-Mi¢ié, D. (272) 21 The in vitro pharmacological characterization of naloxone benzoylhy-
Belfast, M., see Glaser, K. (281) 107 drazone (277) 257
Bello, R., see Barrachina, M.D. (281) R3 Bessho, H., see He, H. (273) 209
Belloni, P., see Vigand, T. (291) 201 Besson, J.-M., see Honoré, P. (272) 249
Beloshapko, G., see Lee, J.H. (285) 25 Bétoin, F., Advenier, C., Fardin, V., Wilcox, G., Lavarenne, J. and
Belvisi, M., Bares, P.J., Larkin, S., Yacoub, M., Tadjkarimi, S., Eschalier, A.
Williams, T.J. and Mitchell, J.A. In vitro and in vivo evidence for a tachykinin NK , receptor antago-
Nitric oxide synthase activity is elevated in inflammatory lung disease nist effect of vapreotide, an analgesic cyclic analog of somatostatin
in humans (283) 255 (279) 241
Benazzouz, A., Boraud, T., Dubédat, P., Boireau, A., Stutzmann, J.-M. Betto, P., see Popoli, P. (287) 215
and Gross, C. Beyermann, M., see Cross, L.J.M. (291) 291
Riluzole prevents MPTP-induced parkinsonism in the rhesus monkey: Bianchi, G., see Micheletti, R. (286) 147
a pilot study (284) 299 Bianchi, N., see Feriotto, G. (290) 85
Bench, C.J., see Pike, V.W. (283) R1 Bickerdike, M.J., Marsden, C.A., Dourish, C.T. and Fletcher, A.
Benediktsdéttir, V.E., Skdladéttir, G.V. and Gudbjarnason, S. The influence of 5-hydroxytryptamine re-uptake blockade on CCK
Effects of ageing and adrenergic stimulation on a,- and B-adrenocep- receptor antagonist effects in the rat elevated zero-maze (271) 403
tors and phospholipid fatty acids in rat heart (289) 419 Biegon, A., see Eshhar, N. (283) 19
Benelli, A., see Poggioli, R. (271) 253 Bielanski, W., see Konturek, S.J. (278) 203
Benelli, A., see Poggioli, R. (287) 207 Bienert, M., see Cross, L.J.M. (291) 291
Bengen, J., see Galle, J. (273) 311 Bill, D.J., see Forster, E.A. (281) 81
Bengtsson, A., see Jackson, D.M. (282) 137 Billard, J.-M., see Jouvenceau, A. (281) 131
Benishin, C.G., see Sun, Y.-D. (271) 453 Binhara, I.M., see Medeiros, M.V. (285) 109
Benrath, J., Eschenfelder, C., Zimmermann, M. and Gillardon, F. Binnekade, R., see Schmidt, E.D. (285) 317
Calcitonin gene-related peptide, substance P and nitric oxide are Birch, P., see Smith, G. (271) 481
involved in cutaneous inflammation following ultraviolet irradiation Bimbaum, L.S., see Brouwer, A. (293) |
(293) 87 Bjorklund, M., see Jakala, P. (282) 39
Benrath, J., see Gillardon, F. (293) 395 Bjém, M., see Idanpaan-Heikkila, J.J. (292) 191
Benthem, L., see Coppes, R.P. (274) 33 Black, J.L., see Anticevich, $.Z. (284) 221
Berdeu, D., Gross, R., Puech, R., Loubatitres-Mariani, M.-M. and Black, J.L., see Yang, K.X.F. (275) 283
Bertrand, G. Black, P.N., see Young, P.G. (273) 137
Evidence for two different imidazoline sites on pancreatic B cells and Blair, T.A., see Lee, K. (285) 309
vascular bed in rat (275) 91 Blanchard, J.-C., see Petitet, F. (291) 143
Beresford, 1.J.M., Sheldrick, R.L.G., Ball, D.I., Turpin, M.P., Walsh, Blanchet, G., see Bodjarian, N. (289) 291
D.M., Hawcock, A.B., Coleman, R.A., Hagan, R.M. and Tyers, M.B. Bland-Ward, P.A., see Gaffen, Z. (271) 445
GR159897, a potent non-peptide antagonist at tachykinin NK, recep- Blandizzi, C., Natale, G., Colucci, R., Carignani, D., Lazzeri, G. and
tors (272) 241 Del Tacca, M.
Berger, I., Gillis, R.A., Vitagliano, S., Panico, W.H., Magee, S., Kelly, Characterization of a,-adrenoceptor subtypes involved in the modula-
M., Norman, W.P., McManigle, J.E. and DaSilva, A.M.T. tion of gastric acid secretion (278) 179
NMDA receptors are involved at the ventrolateral nucleus tractus Blengio, M., see Ferretti, C. (280) 19
solitarii for termination of inspiration (277) 195 Blier, P., see Mongeau, R. (271) 121
Bergstrom, D.A., see Kreiss, D.S. (277) 209 Block, F., see Schwarz, M. (276) 247
Berkowitz, D.E., Nardone, N.A., Smiley, R.M., Price, D.T., Kreutter, Blommaert, A., see Noble, F. (273) 145
D.K., Fremeau, R.T. and Schwinn, D.A. Blommaert, A.G.S., see Valverde, O. (286) 79
Distribution of 8,-adrenoceptor mRNA in human tissues (289) 223 Blumberg, P.M., see Szallasi, A. (289) 181
Berlan, M., see Bousquet-Mélou, A. (289) 235 Blundell, J.E., see Garosi, V.L. (276) 285
Bemabeu, R., see Fin, C. (271) 227 Bobimac, I., see Schoeffter, P. (289) 163
Bernauer, W. Bockaert, J., see Zumbihl, R. (288) 9
Effect of antiarrhythmics on the release of adenosine in rat hearts with Béckmann, S. and Paegelow, I.
coronary occlusion and reperfusion (283) 91 Bradykinin receptors and signal transduction pathways in peritoneal
Bemier, S.G., Fournier, A. and Guillemette, G. guinea pig macrophages (291) 159
A specific binding site recognizing a fragment of angiotensin II in Bodelsson, G. and Stjernquist, M.
bovine adrenal cortex membranes (271) 55 Characterization of contractile adrenoceptors in the human umbilical
Bemier, S.G., Servant, G., Boudreau, M., Fournier, A. and Guillemette, artery (282) 95
G. Bodjarian, N., Carpentier, P., Baubichon, D., Blanchet, G. and Lallement,
Characterization of a binding site for angiotensin IV on bovine aortic G.
endothelial cells (291) 191 Involvement of non-muscarinic receptors in phosphoinositide sig-
Berrang, B., see Popik, P. (291) 221 nalling during soman-induced seizures (289) 291